evolution of metabolic pathways
Recently Published Documents


TOTAL DOCUMENTS

44
(FIVE YEARS 1)

H-INDEX

14
(FIVE YEARS 0)

2021 ◽  
Author(s):  
Lorena Fernández-Cabezón ◽  
Antonin Cros ◽  
Pablo I. Nikel

ABSTRACTDeveloping complex phenotypes in industrially-relevant bacteria is a major goal of metabolic engineering, which encompasses the implementation of both rational and random approaches. In the latter case, several tools have been developed towards increasing mutation frequencies—yet the precise spatiotemporal control of mutagenesis processes continues to represent a significant technical challenge. Pseudomonas species are endowed with one of the most efficient DNA mismatch repair (MMR) systems found in bacteria. Here, we investigated if the endogenous MMR system could be manipulated as a general strategy to artificially alter mutation rates in Pseudomonas species. To bestow a conditional mutator phenotype in the platform bacterium Pseudomonas putida, we constructed inducible mutator devices to modulate the expression of the dominant-negative mutLE36K allele. Regulatable overexpression of mutLE36K in a broad-host-range, easy-to-cure plasmid format resulted in a transitory inhibition of the MMR machinery, leading to a significant increase (up to 438-fold) in mutation frequencies and a heritable fixation of genome mutations. Following such accelerated mutagenesis-followed-by selection approach, three phenotypes were successfully evolved: resistance to antibiotics streptomycin and rifampicin and reversion of a synthetic uracil auxotrophy. Thus, these mutator devices could be applied to accelerate evolution of metabolic pathways in long-term evolutionary experiments, alternating cycles of (inducible) mutagenesis coupled to selection schemes.


2019 ◽  
Vol 476 (14) ◽  
pp. 2059-2092 ◽  
Author(s):  
Javier O. Cifuente ◽  
Natalia Comino ◽  
Beatriz Trastoy ◽  
Cecilia D'Angelo ◽  
Marcelo E. Guerin

Abstract The evolution of metabolic pathways is a major force behind natural selection. In the spotlight of such process lies the structural evolution of the enzymatic machinery responsible for the central energy metabolism. Specifically, glycogen metabolism has emerged to allow organisms to save available environmental surplus of carbon and energy, using dedicated glucose polymers as a storage compartment that can be mobilized at future demand. The origins of such adaptive advantage rely on the acquisition of an enzymatic system for the biosynthesis and degradation of glycogen, along with mechanisms to balance the assembly and disassembly rate of this polysaccharide, in order to store and recover glucose according to cell energy needs. The first step in the classical bacterial glycogen biosynthetic pathway is carried out by the adenosine 5′-diphosphate (ADP)-glucose pyrophosphorylase. This allosteric enzyme synthesizes ADP-glucose and acts as a point of regulation. The second step is carried out by the glycogen synthase, an enzyme that generates linear α-(1→4)-linked glucose chains, whereas the third step catalyzed by the branching enzyme produces α-(1→6)-linked glucan branches in the polymer. Two enzymes facilitate glycogen degradation: glycogen phosphorylase, which functions as an α-(1→4)-depolymerizing enzyme, and the debranching enzyme that catalyzes the removal of α-(1→6)-linked ramifications. In this work, we rationalize the structural basis of glycogen metabolism in bacteria to the light of the current knowledge. We describe and discuss the remarkable progress made in the understanding of the molecular mechanisms of substrate recognition and product release, allosteric regulation and catalysis of all those enzymes.


2019 ◽  
Vol 18 (1) ◽  
Author(s):  
Zheng Lin Tan ◽  
Xiang Zheng ◽  
Yinan Wu ◽  
Xingjin Jian ◽  
Xinhui Xing ◽  
...  

Molecules ◽  
2018 ◽  
Vol 23 (12) ◽  
pp. 3061 ◽  
Author(s):  
Valentina Roffia ◽  
Antonella De Palma ◽  
Caterina Lonati ◽  
Dario Silvestre ◽  
Rossana Rossi ◽  
...  

Ex vivo lung perfusion (EVLP) is an emerging procedure that allows organ preservation, assessment and reconditioning, increasing the number of marginal donor lungs for transplantation. However, physiological and airflow measurements are unable to unveil the molecular mechanisms responsible of EVLP beneficial effects on lung graft and monitor the proper course of the treatment. Thus, it is urgent to find specific biomarkers that possess these requirements but also accurate and reliable techniques that identify them. The purpose of this study is to give an overview on the potentiality of shotgun proteomic platforms in characterizing the status and the evolution of metabolic pathways during EVLP in order to find new potential EVLP-related biomarkers. A nanoLC-MS/MS system was applied to the proteome analysis of lung tissues from an optimized rat model in three experimental groups: native, pre- and post-EVLP. Technical and biological repeatability were evaluated and, together with clustering analysis, underlined the good quality of data produced. In-house software and bioinformatics tools allowed the label-free extraction of differentially expressed proteins among the three examined conditions and the network visualization of the pathways mainly involved. These promising findings encourage further proteomic investigations of the molecular mechanisms behind EVLP procedure.


Biomolecules ◽  
2018 ◽  
Vol 8 (4) ◽  
pp. 132 ◽  
Author(s):  
Alina Perrone ◽  
Natalia Milduberger ◽  
Alicia Fuchs ◽  
Patricia Bustos ◽  
Jacqueline Bua

Trypanosoma cruzi is the etiological agent of Chagas disease. It affects eight million people worldwide and can be spread by several routes, such as vectorborne transmission in endemic areas and congenitally, and is also important in non-endemic regions such as the United States and Europe due to migration from Latin America. Cyclophilins (CyPs) are proteins with enzymatic peptidyl-prolyl isomerase activity (PPIase), essential for protein folding in vivo. Cyclosporin A (CsA) has a high binding affinity for CyPs and inhibits their PPIase activity. CsA has proved to be a parasiticidal drug on some protozoa, including T. cruzi. In this review, we describe the T. cruzi cyclophilin gene family, that comprises 15 paralogues. Among the proteins isolated by CsA-affinity chromatography, we found orthologues of mammalian CyPs. TcCyP19, as the human CyPA, is secreted to the extracellular environment by all parasite stages and could be part of a complex interplay involving the parasite and the host cell. TcCyP22, an orthologue of mitochondrial CyPD, is involved in the regulation of parasite cell death. Our findings on T. cruzi cyclophilins will allow further characterization of these processes, leading to new insights into the biology, the evolution of metabolic pathways, and novel targets for anti-T. cruzi control.


Author(s):  
Luana Presta ◽  
Marco Fondi ◽  
Giovanni Emiliani ◽  
Renato Fani

Bioengineered ◽  
2014 ◽  
Vol 5 (6) ◽  
pp. 347-356 ◽  
Author(s):  
Alejandro Luque ◽  
Sarra C Sebai ◽  
Vincent Sauveplane ◽  
Odile Ramaen ◽  
Rudy Pandjaitan

2014 ◽  
Vol 23 ◽  
pp. 123-135 ◽  
Author(s):  
Alejandro Luque ◽  
Sarra C. Sebai ◽  
Beatrix Santiago-Schübel ◽  
Yann Le Coz ◽  
Delphine Jenot ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document